Aurinia Pharmaceuticals (AUPH) Non-Current Deffered Revenue (2016 - 2026)
Aurinia Pharmaceuticals' (AUPH) quarterly Non-Current Deffered Revenue came in at $12.4 million in Q1 2026, little changed YoY from $12.4 million in Q1 2025, and down 1.86% on a QoQ basis from $12.6 million in Q4 2025.
Aurinia Pharmaceuticals (AUPH) Non-Current Deffered Revenue (2016 - 2026) Analysis & Trends
Aurinia Pharmaceuticals (AUPH) has 7 years of Non-Current Deffered Revenue data on file, last reported at $12.4 million in Q1 2026.
- Quarterly Non-Current Deffered Revenue changed 0.3% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (changed 0.3% YoY) and the FY2025 annual result came in at $12.6 million, up 644.44% from the prior year.
- Non-Current Deffered Revenue retreated to $12.4 million in Q1 2026, from $12.6 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $12.6 million in Q4 2025 to a low of $1.7 million in Q4 2024.
- A 3-year average of $10.6 million and a median of $12.4 million in 2025 frame the typical range for Non-Current Deffered Revenue.
- Annual changes were most pronounced in 2025 — Non-Current Deffered Revenue jumped 644.44% — and 2026, when it dropped 0.3%.
- Tracing AUPH's Non-Current Deffered Revenue over 3 years: stood at $1.7 million in 2024, then jumped by 644.44% to $12.6 million in 2025, then retreated by 1.86% to $12.4 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $12.4 million (Q1 2026), $12.6 million (Q4 2025), and $12.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 220.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Aurinia Pharmaceuticals | 2.06 Bn | 1.61 Bn | 76.67 Mn | 7.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.48 Mn |
| Mar 31, 2026 | 12.41 Mn |
| Dec 31, 2025 | 12.65 Mn |
| Sep 30, 2025 | 12.25 Mn |
| Jun 30, 2025 | 12.35 Mn |
| Mar 31, 2025 | 12.45 Mn |
| Dec 31, 2024 | 1.70 Mn |
| Dec 31, 2019 | 206,000.00 |
| Dec 31, 2018 | 324,000.00 |
| Dec 31, 2017 | 442,000.00 |
| Dec 31, 2016 | 560,000.00 |